News Archive
Holiday Closure & Shipping Information
MRC Holland will be closed from December 25, 2023 until January 2, 2024.
New Packaging for Several Products
Some of our products have a new, neutrally coloured packaging to highlight the use of these products across different MRC Holland technologies
New Customs Regulations Outside EU
We would like to remind our non-EU customers who order directly from MRC Holland that we are required to add a surcharge of €0.01 on Sample DNAs (SDs) that are included as accessory items with selected MLPA assays.
Breast Cancer Awareness Month
It is estimated 1 in every 8 women will develop breast cancer in their lifetime, of which 5 to 10 percent will be hereditary. Understanding breast cancer risk and early detection are crucial to provide the best care to patients and at-risk individuals. At MRC Holland, we proudly offer a wide range of assays to help with identifying hereditary breast cancer and at-risk individuals.
Wanted: Positive DNA Samples
MRC Holland is looking for positive samples to be used in testing and developing of our products
MRC Holland Prices in 2024
Effective from 1 January 2024, we will be implementing a price increase of approximately 8% on most of our products.
SMA Awareness Month
August is SMA Awareness Month! Spinal Muscular Atrophy (SMA) is a neuromuscular disease where the body loses control over the muscle movements. Early detection and treatment of SMA are vital for improved outcomes.
Glioblastoma Awareness Day
Today is Glioblastoma Awareness Day, highlighting the need for improved treatment options for this aggressive type of brain cancer.
Introducing Our digitalMLPA Data Demo Sets: Explore the Potential of SALSA® digitalMLPA™ Probemixes
We are excited to announce the release of our comprehensive digitalMLPA data sets, showcasing sample data from various SALSA® digitalMLPA™ applications: D001 Hereditary Cancer, D006 Multiple Myeloma and D007 Acute Lymphoblastic Leukemia.
Research Highlight: New Genetic Scoring Guide for B-ALL Using SALSA® digitalMLPA™ Probemix D007 Acute Lymphoblastic Leukemia
In a recent research article published in the British Journal of Cancer, Bedics et al. developed a new B-ALL classifier using SALSA digitalMLPA Probemix D007 Acute Lymphoblastic Leukemia.